Status:
UNKNOWN
Africa Ready Malaria Screening
Lead Sponsor:
University of Ghana
Collaborating Sponsors:
Shai-Osudoku District Hospital
Kumasi Technical University
Conditions:
Malaria
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study aims to develop immuno-analytical assays for testing the titres of malaria antibodies in Ghanaian patients' and/or donors' sera using a recombinantly produced MSP119 fusion protein and/or M...
Detailed Description
In this study, immuno-analytical assays will be developed for determining the titres of malaria antibodies in sera of two groups (malaria patients and donors/healthy volunteers) using a recombinantly ...
Eligibility Criteria
Inclusion
- Patients with confirmed malaria (uncomplicated and complicated cases) are diagnosed by the national guidelines.
- Healthy individuals without confirmed malaria per the national guidelines.
- Adults and parents or guardians of children below 12 years willing to participate based on signed informed consent.
- Willing to give assent to adolescents between the ages of 12 and below 18 years.
- Willing to give a blood sample for the necessary investigations as explained in the informed consent.
- Willing to adhere to study procedures and a follow-up visit at the clinic, hospital, or health facility.
Exclusion
- Anyone refusing informed consent (or assent for adolescents) to be part of the study.
- Refusal to study procedures or giving of sample for the necessary investigations.
Key Trial Info
Start Date :
September 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2025
Estimated Enrollment :
1640 Patients enrolled
Trial Details
Trial ID
NCT06153862
Start Date
September 23 2022
End Date
September 1 2025
Last Update
December 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shai-Osudoku District Hospital
Dodowa, Outside North America, Ghana, GAR